Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiol Therapeutics (CRDL) Depreciation & Amortization (CF): 2020-2024

Historic Depreciation & Amortization (CF) for Cardiol Therapeutics (CRDL) over the last 5 years, with Dec 2024 value amounting to $118,877.

  • Cardiol Therapeutics' Depreciation & Amortization (CF) fell 6.60% to $25,582 in Q3 2022 from the same period last year, while for Sep 2022 it was $111,067, marking a year-over-year change of. This contributed to the annual value of $118,877 for FY2024, which is 2.15% down from last year.
  • Cardiol Therapeutics' Depreciation & Amortization (CF) amounted to $118,877 in FY2024, which was down 2.15% from $121,485 recorded in FY2023.
  • Cardiol Therapeutics' 5-year Depreciation & Amortization (CF) high stood at $121,485 for FY2023, and its period low was $104,194 during FY2022.
  • For the 3-year period, Cardiol Therapeutics' Depreciation & Amortization (CF) averaged around $114,852, with its median value being $118,877 (2024).
  • As far as peak fluctuations go, Cardiol Therapeutics' Depreciation & Amortization (CF) declined by 3.97% in 2022, and later grew by 16.59% in 2023.
  • Yearly analysis of 5 years shows Cardiol Therapeutics' Depreciation & Amortization (CF) stood at $108,310 in 2020, then climbed by 0.18% to $108,504 in 2021, then declined by 3.97% to $104,194 in 2022, then rose by 16.59% to $121,485 in 2023, then dropped by 2.15% to $118,877 in 2024.